An antibody that binds HER2 receptor in a composition for treating endometrial, lung, colon or bladder cancer

The use of an antibody, which binds HER2 growth factor receptor, in the preparation of a medicament for treating a cancer characterised by an overexpression of the HER2 receptor in a mammal is described. Cancers suitable for such treatment include, breast, ovarian, stomach, endometrial, salivary gla...

Full description

Saved in:
Bibliographic Details
Main Authors OVERCASHIER, DAVID E, LAM, XANTHE M, HSU, CHUNG C, WU, SYLVIA SAU-YAN, YANG, JANET YU-FENG, ANDYA, JAMES, CLELAND, JEFFREY L, SHIRE, STEVEN J
Format Patent
LanguageEnglish
Published 30.11.2001
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The use of an antibody, which binds HER2 growth factor receptor, in the preparation of a medicament for treating a cancer characterised by an overexpression of the HER2 receptor in a mammal is described. Cancers suitable for such treatment include, breast, ovarian, stomach, endometrial, salivary gland, lung, kidney, colon and bladder cancer, and ductal carcinoma.
Bibliography:Application Number: NZ19960500539